Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism - Université de Bretagne Occidentale Access content directly
Journal Articles Human & Veterinary Medecine Bioflux Year : 2015

Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism

Domains

Immunology
No file

Dates and versions

hal-01260185 , version 1 (21-01-2016)

Identifiers

  • HAL Id : hal-01260185 , version 1

Cite

Cristina Bagacean, Naelle Lombion, Adrian Tempescul, Jean-Christophe Ianotto, Christian Berthou, et al.. Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism. Human & Veterinary Medecine Bioflux, 2015, 7 (4), pp.298-301. ⟨hal-01260185⟩

Collections

UNIV-BREST IMMUNO
54 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More